- Home
- NREF vs LRMR Comparison
NREF vs LRMR Comparison
Compare NREF & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NREF
- LRMR
- Stock Information
- Founded
- NREF 2019
- LRMR N/A
- Country
- NREF United States
- LRMR United States
- Employees
- NREF N/A
- LRMR N/A
- Industry
- NREF Real Estate Investment Trusts
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- NREF Real Estate
- LRMR Health Care
- Exchange
- NREF Nasdaq
- LRMR Nasdaq
- Market Cap
- NREF 264.1M
- LRMR 309.8M
- IPO Year
- NREF 2020
- LRMR N/A
- Fundamental
- Price
- NREF $15.27
- LRMR $3.96
- Analyst Decision
- NREF Hold
- LRMR Strong Buy
- Analyst Count
- NREF 4
- LRMR 8
- Target Price
- NREF $14.75
- LRMR $17.88
- AVG Volume (30 Days)
- NREF 35.7K
- LRMR 1.4M
- Earning Date
- NREF 10-30-2025
- LRMR 10-29-2025
- Dividend Yield
- NREF 13.12%
- LRMR N/A
- EPS Growth
- NREF N/A
- LRMR N/A
- EPS
- NREF 2.59
- LRMR N/A
- Revenue
- NREF $121,573,000.00
- LRMR N/A
- Revenue This Year
- NREF $27.27
- LRMR N/A
- Revenue Next Year
- NREF $5.40
- LRMR N/A
- P/E Ratio
- NREF $5.89
- LRMR N/A
- Revenue Growth
- NREF 302.49
- LRMR N/A
- 52 Week Low
- NREF $12.14
- LRMR $1.61
- 52 Week High
- NREF $18.09
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- NREF 57.04
- LRMR 54.32
- Support Level
- NREF $15.04
- LRMR $3.78
- Resistance Level
- NREF $15.60
- LRMR $4.26
- Average True Range (ATR)
- NREF 0.32
- LRMR 0.26
- MACD
- NREF -0.01
- LRMR 0.00
- Stochastic Oscillator
- NREF 54.76
- LRMR 55.89
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.